COLON ADENOCARCINOMA
Clinical trials for COLON ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new COLON ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for COLON ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major trial tests if boosting immune system can stop colon Cancer's return
Disease control OngoingThis large study is testing if adding a drug called atezolizumab, which helps the body's immune system fight cancer, to standard chemotherapy works better than chemotherapy alone. It's for patients with stage III colon cancer that has been surgically removed but has a high risk o…
Matched conditions: COLON ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug combo aims to stop aggressive colon Cancer's return
Disease control OngoingThis study is for people with a specific type of stage II or III colon cancer who have already had surgery and chemotherapy. It tests whether adding a new, targeted two-drug treatment after the standard care is better at keeping the cancer from coming back, compared to just watch…
Matched conditions: COLON ADENOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug duo tested for Tough-to-Treat colon cancer
Disease control OngoingThis study is testing whether a combination of two drugs, cabozantinib and nivolumab, can help control advanced colorectal cancer that has stopped responding to standard treatments. It will involve about 48 adults whose cancer has spread and is a specific type called microsatelli…
Matched conditions: COLON ADENOCARCINOMA
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Major trial tests new weapon against colon Cancer's return
Disease control OngoingThis large study tested whether adding a targeted drug (bevacizumab) to standard chemotherapy helps prevent cancer from returning in patients with high-risk stage II colon cancer who have had surgery. Over 2,400 patients were randomly assigned to receive either standard chemother…
Matched conditions: COLON ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Scientists hunt for genetic clues to rising colon cancer in young adults
Knowledge-focused OngoingThis study aims to understand why some people develop colorectal cancer at a young age (18-50) by comparing them to those diagnosed later in life. Researchers are collecting genetic information, medical histories, and lifestyle data from 818 patients and their family members to i…
Matched conditions: COLON ADENOCARCINOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Apr 04, 2026 00:36 UTC